Medical Treatment: Clinical Trials

9 trials for Medical Treatment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 3 unknown, 1 completed, 1 not yet recruiting. 7 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable7Recruiting 3, Unknown 2, Completed 1, Not yet recruiting 1

Follow Medical Treatment: new trials by email Literature Review of Medical Treatment trials Research Report on Medical Treatment

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Investigation to Assess the Effects of Drug-COATED Balloons for Treatment of Plaques Erosions Causing Acute Coronary Syndromes
PCI with size matched DCB, GP IIbIIIa inhibitor or heparin & dual antiplatelet therapy - Myocardial Infarction, Percutaneous Coronary Intervention (PCI)
Not applicableNot yet recruiting3W-Research Collaboration Group622026-10-012026-08-25
Standard Urotherapy for Dysfunctional Voiding in Children
Standard urotherapy (SUT) alone., Sham control - Dysfunctional Voiding, Medical Treatment
Not applicableCompletedTanta University1402025-02-262026-08-03
Thrombectomy Versus Best Medical Management in Large Vessel Occlusion Stroke Patients Presenting Beyond 24 Hours and With Presence of Collateral Flow on CT Angiography
Endovascular Thrombectomy - Stroke Acute, Thrombectomy
Not applicableRecruitingTianjin Huanhu Hospital3502024-06-252024-10-23
Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure
Transcatheter PFO closure, Optimal medical treatment - Patent Foramen Ovale, Cryptogenic Stroke
Not applicableRecruitingJosep Rodes-Cabau7142024-06-182026-03-27
Chronic Migraine Prophylaxis: Ultrasound-Guided Greater Occipital Nerve Block Versus Medical Treatment
Greater Occipital Nerve Block, Medical Treatment, bupivacaine or onabotulinum toxin A injection. - Greater Occipital Nerve Block, Medical Treatment
Not applicableUnknownTanta University802022-05-012023-11-08
Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial
Drug Eluting Stent implantation, Aggressive medical treatment, Risk factor management - ICAD - Intracranial Atherosclerotic Disease, ICAS - Intracranial Atherosclerosis
Not applicableRecruitingBeijing Tiantan Hospital3582021-07-022026-07-15
Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study
Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin - Magnetic Resonance Imaging, Asymptomatic Intracranial Stenosis
UnknownAnhui Medical University402020-09-102021-04-20
Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison
Patients - Parkinson's Disease, Dysarthria
Not applicableUnknownCentre National de la Recherche Scientifique, France1202014-01-012016-04-27
KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment
Antipsychotic Treatment, Quality Assurance
TerminatedPsychiatric Centre Rigshospitalet2122003-08-012013-04-16

Narrower conditions

Stroke (3)  ·  Ischemic Stroke (2)  ·  Disease Progression (1)  ·  Dysarthria (1)  ·  Foramen Ovale, Patent (1)  ·  Intracranial Arteriosclerosis (1)  ·  Myocardial Infarction (1)  ·  Parkinson Disease (1)  ·  Patient Satisfaction (1)  ·  Speech (1)

Broader conditions

Brain Diseases (4)  ·  Cardiovascular Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Nervous System Diseases (4)  ·  Vascular Diseases (4)  ·  Cerebrovascular Disorders (3)  ·  Behavior (2)  ·  Heart Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Articulation Disorders (1)  ·  Basal Ganglia Diseases (1)  ·  Cardiovascular Abnormalities (1)

Interventions

Aspirin (1)  ·  Atorvastatin (1)  ·  Bupivacaine (1)  ·  Clopidogrel (1)  ·  Heparin (1)  ·  Percutaneous Coronary Intervention (1)  ·  Risk Factors (1)  ·  Single Person (1)  ·  onabotulinum toxin A (1)

Sponsors

Tanta University (2)  ·  3W-Research Collaboration Group (1)  ·  Anhui Medical University (1)  ·  Beijing Tiantan Hospital (1)  ·  Centre National de la Recherche Scientifique, France (1)  ·  Josep Rodes-Cabau (1)  ·  Psychiatric Centre Rigshospitalet (1)  ·  Tianjin Huanhu Hospital (1)

Countries

China (3)  ·  Egypt (2)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Poland (1)  ·  Portugal (1)

Top investigators

Joaquim J Ferreira, M.D, Ph.D. (1)  ·  Karin Byrsting (1)  ·  Marianne Jacoby (1)  ·  Michael Maagensen (1)  ·  Peter Christoffersen (1)  ·  Serge Pinto, Ph.D. (1)  ·  Soren Blikenberg (1)  ·  Yongjun Wang, MD (1)  ·  Zhongrong Miao, MD (1)

Results publications

PMID 27856480